Artiva Biotherapeutics, Inc To Start Trading Tomorrow
Artiva Biotherapeutics, Inc To Start Trading Tomorrow
Artiva Biotherapeutics, Inc (NASDAQ:ARTV) IPO will take place July, 19 on the NASDAQ exchange under the ticker ARTV.
Artiva Biotherapeutics, Inc（納斯達克股票代碼：ARTV）的首次公開募股將於7月19日在納斯達克交易所進行，股票代碼爲ARTV。
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on January 15, 2025.
該公司發行股票的預期價格在每股14.00美元至16.00美元之間，內部封鎖期爲180天，將於2025年1月15日結束。
See also: Benzinga IPO Calendar
另見：Benzinga IPO 日曆
About Artiva Biotherapeutics, Inc
Artiva 生物治療公司簡介
Artiva Biotherapeutics, Inc is a clinical-stage biotechnology company focused on developing NK cell-based therapies for patients suffering from devastating autoimmune diseases and cancers.
Artiva Biotherapeutics, Inc是一家處於臨床階段的生物技術公司，專注於爲患有毀滅性自身免疫性疾病和癌症的患者開發基於Nk細胞的療法。
See also: Benzinga's Most Shorted Stocks
另見：本辛加最常做空的股票
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。